Form 8-K ARTELO BIOSCIENCES, INC. For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Artelo Biosciences terminates at-the-market offering agreement
May 15, 2026 4:03 PM EDTArtelo Biosciences Inc. (NASDAQ: ARTL) terminated its at-the-market offering agreement with R.F. Lafferty & Co., Inc., the company announced. The termination notice was provided on May 11, 2026, with the agreement ending on May 18, 2026.
The sales agreement, originally dated July 18, 2025, allowed Artelo to sell... More
